Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on August 11, 2026.

2.08% of the capital sold short

3 disclosing funds

428 disclosures on record

SE0002148817 ISIN code

Evolution of the disclosed total

0%2%4%6%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

The whole history, peaking at 4.82% on March 10, 2025. The shaded band is the year shown above.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
Fund	% of capital	Over the year	Since
ActusRayPartners Limited	0.89%	+0.29 pt	August 7, 2026
GSA Capital Partners LLP	0.60%	+0.06 pt	August 6, 2026
Connor Clark & Lunn Investment Management Ltd.	0.59%	-0.02 pt	August 11, 2026

On the other side: the funds that hold Hansa Biopharma AB Titelia

History of disclosures

428 disclosures on record for this share.
Date	Fund	% of capital	End of publication
September 12, 2022	Millennium International Management LP	0.63%	still open
September 8, 2022	Millennium International Management LP	0.50%	still open
September 7, 2022	Arrowstreet Capital Limited Partnership	0.51%	still open
August 18, 2022	Citadel Advisors LLC	0.53%	still open
July 20, 2022	PDT Partners LLC	0.52%	still open
June 28, 2022	Arrowstreet Capital Limited Partnership	0.56%	still open
June 8, 2022	Arrowstreet Capital Limited Partnership	0.68%	still open
May 31, 2022	Millennium International Management LP	0.00%	still open
May 27, 2022	Millennium International Management LP	0.60%	still open
May 25, 2022	Millennium International Management LP	0.53%	still open
May 3, 2022	Marshall Wace LLP	0.00%	still open
April 27, 2022	Marshall Wace LLP	0.50%	still open
April 11, 2022	Marshall Wace LLP	0.00%	still open
April 6, 2022	Arrowstreet Capital Limited Partnership	0.77%	still open
April 6, 2022	Worldquant LLC	0.00%	still open
April 5, 2022	Marshall Wace LLP	0.57%	still open
April 4, 2022	Worldquant LLC	0.57%	still open
March 30, 2022	Marshall Wace LLP	0.67%	still open
March 23, 2022	Worldquant LLC	0.69%	still open
March 22, 2022	Marshall Wace LLP	0.78%	still open
March 22, 2022	Systematica Investments Limited	0.00%	still open
March 9, 2022	Marshall Wace LLP	0.89%	still open
March 9, 2022	Worldquant LLC	0.70%	still open
March 9, 2022	Systematica Investments Limited	0.59%	still open
March 7, 2022	Worldquant LLC	0.63%	still open
February 28, 2022	Marshall Wace LLP	0.90%	still open
February 25, 2022	Worldquant LLC	0.51%	still open
February 24, 2022	Worldquant LLC	0.00%	still open
February 22, 2022	Marshall Wace LLP	0.89%	still open
February 11, 2022	Systematica Investments Limited	0.60%	still open
February 7, 2022	Worldquant LLC	0.51%	still open
January 20, 2022	Marshall Wace LLP	0.99%	still open
January 18, 2022	Systematica Investments Limited	0.50%	still open
January 14, 2022	Marshall Wace LLP	1.06%	still open
January 7, 2022	Marshall Wace LLP	1.16%	still open
January 4, 2022	Marshall Wace LLP	1.22%	still open
December 29, 2021	Marshall Wace LLP	1.13%	still open
December 23, 2021	Marshall Wace LLP	1.00%	still open
November 26, 2021	Marshall Wace LLP	0.92%	still open
November 18, 2021	Marshall Wace LLP	0.82%	still open
November 16, 2021	Worldquant LLC	0.00%	still open
November 10, 2021	Marshall Wace LLP	0.79%	still open
November 9, 2021	Worldquant LLC	0.56%	still open
November 4, 2021	Worldquant LLC	0.69%	still open
November 1, 2021	Marshall Wace LLP	0.89%	still open
October 21, 2021	Capital Fund Management SA	0.00%	still open
October 14, 2021	Worldquant LLC	0.77%	still open
October 12, 2021	Marshall Wace LLP	0.99%	still open
October 11, 2021	Worldquant LLC	0.81%	still open
October 8, 2021	Marshall Wace LLP	1.00%	still open

Other companies sold short in Sweden

Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
Elekta AB (publ) 10.19% of the capital sold short
JM AB 7.01% of the capital sold short
Hemnet Group AB (publ) 6.08% of the capital sold short
Bonesupport Holding AB 5.58% of the capital sold short
Truecaller AB 5.43% of the capital sold short
Embracer Group AB 5.25% of the capital sold short
Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
Tobii AB 4.34% of the capital sold short
Dynavox Group AB 4.30% of the capital sold short
RaySearch Laboratories AB (publ) 4.15% of the capital sold short
Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=4